Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1762)	12/2/1998 3:00:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

Cist's cash and cash receivables per share has gone up factoring in the guaranteed part of the PMC payments. CISTRON now has 58 cents a share in cash and cash receivables.

To: Dr. John M. de Castro who wrote (1762)	12/2/1998 8:54:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

Medimmune and Pasteur Merieux Connaught in a licensing deal similiar to Cist's. MEDI's market value increased $35 million on the news today. With all of Cistron's investment bankers on hand>>> Why is CIST's total market value only $6 million?